Gregson Aric L
Division of Infectious Diseases, Department of Medicine, University of California, Box 957119, Warren Hall 14-154, Los Angeles, CA, 90995-7119, USA.
Curr Infect Dis Rep. 2016 Jul;18(7):21. doi: 10.1007/s11908-016-0529-6.
Survival after lung transplantation is limited in large part due to the high incidence of chronic rejection, known as chronic lung allograft dysfunction (CLAD). Pulmonary infections are a frequent complication in lung transplant recipients, due both to immunosuppressive medications and constant exposure of the lung allograft to the external environment via the airways. Infection is a recognized risk factor for the development of CLAD, and both acute infection and chronic lung allograft colonization with microorganisms increase the risk for CLAD. Acute infection by community acquired respiratory viruses, and the bacteria Pseudomonas aeruginosa and Staphylococcus aureus are increasingly recognized as important risk factors for CLAD. Colonization by the fungus Aspergillus may also augment the risk of CLAD. Fostering this transition from healthy lung to CLAD in each of these infectious episodes is the persistence of an inflammatory lung allograft environment.
肺移植后的生存率在很大程度上受到限制,这主要是由于慢性排斥反应的高发生率,即所谓的慢性肺移植功能障碍(CLAD)。肺部感染是肺移植受者常见的并发症,这既归因于免疫抑制药物,也归因于肺移植通过气道持续暴露于外部环境。感染是公认的CLAD发生的危险因素,急性感染和肺部移植器官被微生物慢性定植都会增加CLAD的风险。社区获得性呼吸道病毒以及铜绿假单胞菌和金黄色葡萄球菌引起的急性感染越来越被认为是CLAD的重要危险因素。曲霉菌的定植也可能增加CLAD的风险。在每一次这些感染发作中,促使从健康肺向CLAD转变的是炎症性肺移植环境的持续存在。